Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21123449 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
Conditions: Polycystic Ovary Syndrome;   Obstructive Sleep Apnea
Interventions: Device: continuous positive airway pressure (CPAP);   Drug: depot leuprolide plus estrogen/progestin replacement;   Drug: pioglitazone;   Procedure: REM frag;   Procedure: SWS supp
2 Recruiting Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
Conditions: Polycystic Ovary Syndrome;   Obstructive Sleep Apnea
Interventions: Drug: Depot Lupron followed by estrogen plus placebo;   Drug: Depot Lupron followed by progesterone plus placebo.;   Device: CPAP

Indicates status has not been verified in more than two years